Catalyst Wire Dossier Catalyst Wire Dossier

acellular pertussis vaccine (Pa)

acellular pertussis vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for acellular pertussis vaccine (Pa), covering 2017-02-08 to 2017-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine [Phase 2]

See pricing